No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MRNA241213C38000
- 3.60
- 0.000.00%
15min DelayTrading Dec 10 14:19 ET
0.00High0.00Low
0.00Open3.60Pre Close0 Volume103 Open Interest38.00Strike Price0.00Turnover93.82%IV-1.27%PremiumDec 13, 2024Expiry Date4.14Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9201Delta0.0483Gamma9.86Leverage Ratio-0.0915Theta0.0021Rho9.07Eff Leverage0.0049Vega
Intraday
- 5D
- Daily
News
Moderna Reinstated With an Underperform at BofA
BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41
BofA Downgrades Moderna, Says It's 'Tough Time' to Be Vaccine Maker
BofA Restarts Coverage of 11 Large-cap Biopharmas
FDA Highlights Safety Challenges And Development Needs For Pediatric RSV Vaccines Amid Historical Concerns And Recent MRNA Trial Pauses; Focus On Addressing Unmet Needs For Infants And Toddlers.
Unpacking the Latest Options Trading Trends in Moderna